Written Question · S1W-11383 · Session 1
Further to the answer to question S1W-8411 by Susan Deacon on 13 July 2000, what advice it has received from the Health Technology Board re…
The question
To ask the Scottish Executive, further to the answer to question S1W-8411 by Susan Deacon on 13 July 2000, what advice it has received from the Health Technology Board regarding the clinical and cost effectiveness of beta interferon as a treatment for multiple sclerosis and whether it will place a copy of any such advice in the Scottish Parliament Information Centre.
The answer
A copy of a letter from the Health Technology Board for Scotland (HTBS) giving an update on its work to provide advice to NHSScotland on the clinical and cost effectiveness of beta interferon as a treatment for multiple sclerosis has been placed in the Parliament's Reference Centre.
In the Official Report
No contribution in the Official Report cites S1W-11383 by reference.